// company-profile
Lb Pharmaceuticals Inc Insider Trading
LBRXEvery SEC Form 4 insider trading filing for Lb Pharmaceuticals Inc (LBRX) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=LBRX" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares (net $10.0M). Buying was led by Deep Track Biotechnology Master Fund, Ltd..
// 90-day insight
Over the last 90 days, Lb Pharmaceuticals Inc insiders bought $10.0M across 8 transactions with no open-market sales.
- Most active insider: Deep Track Biotechnology Master Fund, Ltd. with 1 transaction totaling $10.0M.
- Largest single purchase: $10.0M by Deep Track Biotechnology Master Fund, Ltd. on Jul 30, 2026.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Lb Pharmaceuticals Inc as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Deep Track Biotechnology Master Fund, Ltd. | LBRX | Purchase | 286,205 | $34.94 | $10.00M |
| Jun 3, 2026 | Hemrajani Rekha | LBRX | Award | 10,000 | $0.00 | $0K |
| Jun 3, 2026 | Garland J. Scott | LBRX | Award | 10,000 | $0.00 | $0K |
| Jun 3, 2026 | Nussbaum Ran | LBRX | Award | 10,000 | $0.00 | $0K |
| Jun 3, 2026 | Luse Rebecca | LBRX | Award | 10,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →